Clinical Trials in Maryland

Showing 23001-23020 of 23,284 trials

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

NCT00462189

RATIONALE: The CAT-8015 immunotoxin can bind tumor cells and kill them without harming normal cells. This may be an effective treatment for hairy cell leukemia(HCL) that has not responded to chemotherapy, surgery or radiation therapy. PURPOSE: Phase I dose escalation study to determine the maximum tolerated dose of CAT-8015 immunotoxin in treating patients who have hairy cell leukemia (HCL) that has not responded to treatment.

LeukemiaHairy Cell LeukemiaHCL

Cambridge Antibody Technology40 participantsStarted Apr 2007

Stanford, California, United States • Chicago, Illinois, United States • Bethesda, Maryland, United States +2 more locations

UNKNOWNPhase 117 miles

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

NCT00457860

RATIONALE: The CAT-8015 immunotoxin can bind tumor cells and kill them without harming normal cells. This may be an effective treatment for chronic lymphocytic leukemia (CLL), prolymphocytic leukemia (PLL), or small lymphocytic lymphoma (SLL that has not responded to chemotherapy, surgery or radiation therapy. PURPOSE: Phase I dose escalation study to determine the maximum tolerated dose of CAT-8015 immunotoxin in treating patients who have chronic lymphocytic leukemia, prolymphocytic leukemia or small lymphocytic lymphoma that has not responded to treatment

Leukemia

Cambridge Antibody Technology50 participantsStarted Mar 2007

Beverly Hills, California, United States • Indianapolis, Indiana, United States • Bethesda, Maryland, United States +1 more locations

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

Find Trials by Condition in Maryland

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers

Buprenorphine and Integrated HIV Care Evaluation

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation

Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease

Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

De-Medicalizing Mifepristone Medical Abortion

Quick Start Approach to Birth Control Pills

Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk

VIBRANT Registry: Value of Information Based From Pacemaker Recordings and New Technologies

RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia

Urge Incontinence Bladder Overactivity Study